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Abstract
The paper examines the relationship between the lifetime risk of dying from AIDS and HIV
prevalence, using a female stable population model in which the epidemic has stabilized. In
addition to prevalence, lifetime risk is determined by various other factors, notably the level of
mortality from causes other than AIDS, age at infection, and survival time between infection and
death. Typically, the lifetime risk of dying from AIDS is between three and five times the HIV
prevalence. Regression equations are developed for estimating lifetime  risk from the prevalence
and other parameters. The methods are applied to data for Kenya, and it is shown that the 1995
prevalence estimate of 7.5 per cent for the population aged 15 and over would be equivalent to a
lifetime risk of about 30 per cent.
HIV prevalence, or the proportion of the adult population which is HIV-positive, is the most
commonly used index for measuring the scale of the epidemic. In African countries, national
estimates of HIV prevalence are generally only available for females, as the main source of
data is the anonymous testing of women who use antenatal services. More direct measures of
the effect of HIV could be found from the annual death rate due to AIDS in the adult
population, or the proportion of all adult deaths which are due to AIDS. These measures are
rarely available in practice, as most African countries do not have death registration systems,
and in any case, AIDS deaths are frequently perceived as due to other causes (Boerma et al.
1997). None of the above measures tells us about the overall risk of contracting HIV or dying
from AIDS faced by an individual approaching adulthood and sexual maturity. But this last
measure, which for a disease like AIDS is three or four times as large as the current
prevalence measure, is one which would be very useful to planners and health educators alike.
It would enable those who train skilled workers and professionals to judge what proportion of
their cadres would be lost to this disease before the end of their working lives. It would allow
insurance companies to set realistic premiums in countries affected by the epidemic. And it
could provide a powerful advocacy tool for those trying to persuade young people not to
follow the norm in terms of widely prevalent unsafe sexual behaviour.
HIV prevalence, or the proportion of the adult population which is HIV-positive, is the
most commonly used index for measuring the scale of the epidemic. In African countries,
national estimates of HIV prevalence are generally only available for females, as the main
source of data is the anonymous testing of women who use antenatal services.
This paper investigates the relationship between HIV prevalence and lifetime risk, using
models of age-specific incidence which have been tailored to reflect the type of sexual union
formation patterns observed amongst females in a wide range of African populations. We
focus on females because information on HIV prevalence, participation in sexual unions and
fertility is widely available for females but not for males. The relationships which we discover
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in our model populations enable us to estimate lifetime risk statistics in populations which do
not have the data required to calculate such risks directly.
Although HIV prevalence rates are usually quoted for ‘the adult population’ there is no
generally accepted definition of ‘adult’, and different countries and different modellers adopt
a variety of age ranges in their calculations. In Kenya, the National AIDS Control Programme
defined prevalence relative to the population aged 15 and over, and the estimated figure for
1995 was 7.5 per cent, or about one person in 13. Confronted with this statistic, an
uninformed reader might be tempted to infer that, if one person in 13 has the disease, the
lifetime risk, or the proportion who could expect to contract it during the course of their adult
lives, would also be about one in 13. In reality however the lifetime risk is very much higher
than the prevalence, since the denominator for the prevalence rate consists of those currently
alive, rather than all those who were ever at risk. On the other hand, detailed surveillance
studies of small populations affected by HIV (e.g. Boerma et al. 1997; Nunn et al. 1997) have
shown that at prevalence levels of between five and seven per cent, over 45 per cent of all
adult deaths are due to AIDS. But it would be equally incorrect to assume that the lifetime risk
of dying from AIDS for an adult in these populations was as high as 45 per cent, since the
distribution of deaths by cause is affected by the age structure of the population, and in a
growing population, younger adult ages, in which AIDS deaths predominate, would carry
more weight.
Epidemiologists use a variety of measures to gauge the severity of a disease in a
population. The most commonly used are prevalence:  the proportion of the population
suffering from the disease at a given point in time; and incidence risk:  the annual number of
new cases observed divided by the number of healthy individuals1. The relationship between
prevalence and incidence is determined by the disease duration, which can be equated to
survival time for diseases such as HIV/AIDS, which are generally fatal. In stationary and
stable populations, simple relationships exist between these measures and the lifetime risk of
dying of the disease (Preston 1987).
In a stationary population with a constant size and structure, and in which the number of
births each year is exactly equal to the total number of deaths, these relationships are:
prevalence
prevalence
incidence mean survival time
1-
= ´ . . . 1
lifetime risk
prevalence
mean survival time birth rate
=
´
. . . 2
For a stable epidemic in a stable population, with constant fertility, mortality, and growth
rate, and a constant proportionate age structure, these equations are modified to give the
following approximate relationships:
prevalence
prevalence
incidence mean survival time rd
1 -
» ´ ´ -exp( ) . . . 3
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 Throughout this paper, all the incidence measures used are ‘occurrences/exposure’-type measures, as is
the convention in epidemiology, rather than ‘occurrences/total population’-type measures which are
occasionally referred to as demographic incidence rates, e.g. Hoem 1978.
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lifetime risk
prevalence r a d
mean survival time birth rate
»
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. . . 4
where r is the growth rate of the population, a is the mean age at infection in the population, d
is the mean length of time since infection for those people suffering from the disease, so that
(a+d) is the mean age of persons currently infected2. When prevalence is defined as relating to
a specified age group, then the ‘birth rate’ becomes the number of persons reaching the lower
bound of the age group annually, divided by the total number in the age group. In populations
which are growing in an irregular fashion, due to past changes in vital rates, the values r in
equations 3 and 4 would be replaced by integral expressions of the type r r x t dx
a
= ò ( , )
w
appropriate for the time in question.
Data on all these variables are rarely available, but certain relationships are clear. Thus
lifetime risk is higher when prevalence is higher; survival time is lower (this would also tend
to shorten the mean time since infection); age at incidence is higher; mortality from other
causes is lower (since growth rate will be higher). A low fertility rate might increase lifetime
risk, as it would lower the crude birth rate in the denominator; but it would also reduce the
growth rate in the numerator, so it could act in either direction.
Preston’s equations allow us to appreciate the possible scale of the difference between
prevalence and lifetime risk. Table 1 shows some hypothetical data conforming to the
relationships shown in equation 4, for two different types of fatal disease. Both are assumed to
have a prevalence of two per cent, a survival time of eight years, and a mean duration since
infection of five years. But the cancer-type disease, which is shown occurring in a slow-
growing population (growth rate 1%) has an older pattern of infection (mean age of incidence
50) than the AIDS-type disease (mean age of incidence 25) which is shown in a population
growing at three per cent per annum. If it reached this prevalence level in spite of its old age
pattern, the cancer-type disease would carry a lifetime risk of almost 20 per cent, nearly ten
times its prevalence rate. A disease like AIDS which strikes at earlier ages, at this level of
prevalence would be associated with a lifetime risk over five times its prevalence.
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Table 1
Theoretical relationship between disease prevalence and lifetime risk of dying
(hypothetical data)
Disease
prevalence
Growth
rate
Age at
infection
Duration
since
infection
Survival
time
Birth
rate
Lifetime
risk
Risk
prevalence
Cancer 0.02 0.01 50.00 5.00 8.00 0.02 0.196 9.8
AIDS 0.02 0.03 25.00 5.00 8.00 0.04 0.114 5.7
An empirical example of a large difference between prevalence and lifetime risk is
furnished by the example of maternal mortality. In the Matlab study area of Bangladesh, the
maternal mortality ratio for the period 1976-89 was 5.1 maternal deaths per 1000 live births.
The average total fertility rate during this period was 5.3, so the lifetime risk was about 2.7
per cent3. The incidence of maternal mortality may be taken as the maternal mortality rate of
91 per 100,000 woman-years (Fauveau and Chakraborty 1994). Assuming the average
survival time for a fatal pregnancy to be nine months or 0.75 years, and the mean time since
start of such a pregnancy for a cross-section of women to be half this figure, then with a
growth rate of 1.3 per cent per annum, the prevalence of maternal mortality works out at 69
per 100,000 woman-years. Thus the lifetime risk of maternal mortality is nearly 40 times the
prevalence of fatal pregnancies in this population.
In order to get realistic values for the age pattern of infection and subsequent mortality,
we have used a spreadsheet model originally developed by Zaba (1994) for measuring the
demographic effect of AIDS. This model allows for both behavioural and biological factors to
influence the way HIV builds up in a cohort, and shows the effect of HIV on the growth and
structure of the population. We define prevalence as the proportion HIV-positive among the
population aged 15 and over. Lifetime risk is calculated by finding the number of deaths from
AIDS in a typical cohort using multiple-decrement life table techniques, rather than the
theoretical relationships above. The multiple-decrement approach eliminates the necessity of
calculating statistics such as mean time since infection. A full formal specification of the
model can be found in Zaba (1994), but a list of variable parameters which govern its
operation is shown in Table 2. This table also shows the default values of the parameters and
selected statistics for the default population and the epidemic so generated, as well as the
ranges of the values used for the simulation models described later in this paper. In all our
simulations we generate stable epidemics in stable populations, that is, the results presented
show the relationships between prevalence and lifetime risk in a mature epidemic in which
prevalence has reached an equilibrium level, and where death rates have stabilized along with
the new population age structure.
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lifetime risk maternal mortality ratio total fertility rate= - -1 1( )
HIV prevalence and lifetime risk of dying of AIDS
Supplement 2 to Health Transition Review Volume 7, 1997
49
Table 2
Input parameters and output characteristics of simulation model
Union dynamics
Input parameters Default Range Notes
Women ever entering union 100%
Sexual initiation:
start age
median age
15
20
13 - 17
18 - 22
Coale & McNeil (1972) marriage
model
Union breakdown rate per year 10% 0 - 20% Independent of age or union
duration
Peak annual union re-entry rate 70% 50 - 90% Bell-shaped distribution
Peak age for union re-entry 30 27 - 33
Postpartum abstinence 6 months 3m - 9m Range of variation: 0 - 2 years
Terminal abstinence median age 50 40 - 60 Logistic curve
Coital frequency
new partner
regular partner
0.3
0.06
.15 - .45
.03 - .09
Average declines linearly from
once every 3 days for new unions
to once every 2 weeks for unions
lasting five years or more
Output characteristics (pre HIV)
In active union by age 50 60%
Mean partners by age 50 2.6
Proportion partners dead 5% determined by prevailing
mortality rates
Fecundity
Input parameters
Mean age at
menarche
menopause
13
45
11 - 15
40 - 50
Wood & Weinstein (1988) model
Primary sterility 2%
Maximum secondary sterility 40% 20 - 60% Logistic curve
Breastfeeding amenorrhoea 6 months Shortened after infant death
Postpartum contraception 1.5 yrs 0.0 - 3.0
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Table 2 (cont.)
Input parameters and output characteristics of simulation model
Output characteristics (pre HIV)
Total fertility rate 5.00 jointly determined by fecundity
and union dynamics parameters
Disease severity
Input parameters
Mean survival with HIV:
adult
infant
eight years
1 year
4 - 12
0.5 - 1.5
exponential decay curve
all HIV+ve births die before age
10
Extent of vertical transmission 30% 20 - 40%
Infection risk per coitus:
new partner
regular partner
0.0015
0.00015
0 - .003
0 - .0003
declines linearly over first five
years of new partnership; range
used in simulations 0.0 to 0.0003
for regular partners, new partner
risk is ten times higher
Life expectancy of HIV-negative 60 years Brass logit relational model
Output characteristics (post HIV)
Stable prevalence at ages 15-50 17%
HIV-positive births 6%
Population life expectancy 39 years
Mean age of infection schedule 32 years
Mortality from causes other than AIDS
When discussing lifetime risks, it is necessary to distinguish between gross and net risks. A
gross risk is the probability of a person contracting HIV, assuming that no one in the
population dies from any other cause. A net risk is the proportion who will die of AIDS when
allowance has been made for mortality from other causes. The difference between the gross
and the net risks will of course depend on the level of mortality from causes other than AIDS;
clearly the higher the mortality from other causes, the more likely will people be to die of
something else first.
Since background mortality is a variable which can be manipulated in our model, we
have calculated the net lifetime risks assuming that mortality from causes other than AIDS
can be represented by model life tables with expectations of life at birth of 50, 60 and 70
years. The other variables were held constant at their default values shown in Table 2. The
results are shown in Figure 1. The gross risk increases non-linearly with prevalence, and is
over four times as high. The net risks are substantially smaller than the gross, but even with
the highest level of background mortality, net lifetime risk is more than twice the prevalence.
The lifetime risks shown in the next two figures are all net risks assuming an expectation of
life of 60 years for causes other than AIDS.
Figure 1
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Effect of background mortality level on HIV prevalence and net lifetime risk
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Age at infection
The mean age at infection is primarily determined by the ages at which people become
sexually active. It thus varies from population to population, and between males and females,
being generally younger among the latter. It is also affected by the age structure of the
population, being younger when there is a steep slope on the age distribution. However this
last effect can be eliminated from comparisons of populations if we make the calculations, not
for the living population at a point in time, but for the schedule of incidence risks by age. The
latter will normally be some four or five years older than the former.
Models with mean ages of the risk schedule of 27, 32 and 37 years were constructed.
Survival time was held constant at eight years, and total fertility at five births per woman. The
results are shown in Figure 2. The effects of the age at infection on lifetime risks are moderate
but systematic. The higher the age at infection, the higher the lifetime risk implied by a given
prevalence. This is because when age at infection is higher, the infection is concentrated in a
smaller proportion of the population, so the same prevalence for the 15+ age range could only
be achieved as the result of a higher overall lifetime risk.
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Figure 2
Effect of mean age at infection on HIV prevalence and net lifetime risk
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Survival time after infection
Mean survival times of the HIV-positive are difficult to estimate, since this involves very long
prospective studies, but quite a lot of evidence is now available about median survival times.
Cohort studies of white males in the US have suggested median survival times of ten years
(Chin 1995), and drug therapies are now lengthening this time, but there is reason to suppose
that in Africa it may be substantially less (Anderson 1989; Gregson 1994). Nunn et al. (1997)
estimated median survival time after infection in Masaka district in Uganda as just over five
years for persons infected when they were under age 55, and less than three years for those
infected at later ages. In a simple exponential model of survival of the HIV-positive, such as
used in our model, a mean survival time of eight years is equivalent to a median survival time
of 5.5 years.
In order to explore the effect of survival time on the relationship between lifetime risk
and prevalence, we have used three values of the mean duration: 5, 8 and 11 years. Mean age
of the infection risk schedule was held constant at 32 years. The results are shown in Figure 3.
Again the relationship is strongly affected by the survival time: for a given level of prevalence
within our range, the lifetime risks were between 30 and 65 per cent higher when the mean
duration was five years as against 11 years.
HIV prevalence and lifetime risk of dying of AIDS
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Figure 3
Effect of mean survival time on HIV prevalence and net lifetime risk
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Fertility
As is evident from equation (4), fertility can affect the relationship between prevalence and
lifetime risk in different ways. This is because fertility is the primary determinant of the shape
of the age distribution: lowering fertility reduces the proportion of young people and increases
the proportion of the old. With the mean age at infection held constant at 32 and the mean
survival time at eight years, three sets of models were generated with total fertility rates of
seven, five and three births per woman. The results are illustrated in Figure 4.
It appears that variation in the level of fertility, and hence in the age structure, has very
little effect on the lifetime risk. This means that the relationship in populations with changing
fertility levels will be similar to those observed in stable populations with an intermediate
level of fertility. The explanation lies in the compensating effects of changes in the
proportions of young adults under 25 and of old persons over 50; as one goes up the other
goes down, but as both sections have relatively low prevalence of HIV the changes cancel out.
If prevalence had been defined as the percentage HIV-positive among persons aged 15-49, a
stronger relationship with fertility might have been revealed.
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Figure 4
Effect of fertility level on HIV prevalence and net lifetime risk
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Child and adult risks
The lifetime risks shown in Tables 1 to 4 incorporate both the risks of horizontal transmission
between adults and those of vertical transmission from mothers to children. The balance
between adult and child risks depends on the likelihood of vertical transmission. In this model
we have assumed a 30 per cent probability of an HIV-positive pregnant woman transmitting
the virus to her unborn child, or during delivery or through breastfeeding, and we assume that
all HIV-positive infants die before reaching adulthood. At this level, the risk of dying from
HIV infection in childhood is between seven and ten per cent of the total risk, and the
proportion increases slightly with the prevalence. If, however, we assumed a higher or lower
vertical transmission ratio (VTR), the proportion of child deaths would increase or decrease
correspondingly: with a VTR of 20 per cent childhood deaths constitute 4-6 per cent of total
AIDS deaths; whereas if VTR was as high as 40 per cent, between 9 and 13 per cent of AIDS
deaths would occur in childhood.
Thus the vertical transmission ratio is an important variable in determining the risk of
infection in infancy and childhood, though not in adulthood. As such it is also a component of
lifetime risk, albeit a relatively small one. It has virtually no effect on prevalence, which is
based on the adult population only.
Applications to developing countries
The question now arises whether these models can be used to make realistic calculations of
lifetime risk for Third World countries. Various problems arise in this respect.
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In the first place information on at least two of the crucial variables, mean age at infection
and survival time, is invariably lacking. We have attempted to overcome this problem by
using proxy variables which we expect to be closely related to survival time and mean age at
infection. We have investigated two such proxies which can be calculated from the models
and which might also be available in real populations: the mean age at death of persons dying
of AIDS, and, for females, the mean age at the birth of the first child. Sometimes information
is available on the age distribution of AIDS cases rather than on deaths from AIDS, in which
case the age at death can be approximated by adding half a year to the mean age of the AIDS
cases, since the average survival time after the development of full-blown AIDS is only about
one year; for example Boerma et al. (1997) report a mean duration of illness of ten months
before an AIDS death.
In Africa AIDS cases and deaths from AIDS tend to be seriously underreported. But
unless the degree of underreporting is associated with age, the mean age of the reported cases
should give a reasonable approximation to that of all AIDS deaths. However bias could
clearly arise if the degree of underreporting is greater in rural than in urban areas, and if the
mean age at infection also differs between rural and urban areas.
The mean age of mothers at the birth of their first child should be associated with the
mean age of HIV infection since both are the result of sexual activity. We would expect this
relationship to be much closer in non-contracepting populations, where both pregnancy and
infection are risks associated with sexual activity. But even in non-contracepting populations
we would not necessarily expect the relationship to be fixed; if some cultures allow young
girls to become sexually active before they become fully fecund, the risk of infection will be
raised compared to that of pregnancy. And if sexual activity takes place with more than one
partner, this will raise the risk of infection but not of pregnancy. Furthermore a high
prevalence of primary infertility and high incidence of abortion would also raise infection
risks relative to fertility risks in the population.
The mean age at first birth can readily be obtained from census or survey data on the
distribution of women by parity and age group. Thus the mean age at first birth can be
calculated from the proportions of childless women in each age group in the same way as the
singulate mean age at marriage is obtained from the proportions never-married by age (Hajnal
1953). If there are appreciable numbers of women whose parity was not stated, adjustments
by El Badry's (1961) method may be tried.
Information on median survival times may sometimes be available for African
populations from small-scale longtitudinal studies, from which an informed guess can be
made for the country concerned. On the assumption that the deaths are distributed in an
exponential decay function, the mean values implied by the medians can be calculated. We
have also explored the possibility of estimating survival times given both the mean age at first
birth and mean age at death from AIDS, and have derived the necessary regression equations,
using both ordinary least squares regression and a two-stage (instrumental variables)
procedure, in which the estimate of mean survival time was not made explicit, but was
indirectly fed into the regression estimate of lifetime risk. The results, however, were
disappointing. The regression for mean survival based on the mean age at first birth, mean age
at death from AIDS and prevalence explained only 67 per cent of its variance. The standard
errors of the estimates of mean survival time were disturbingly large, giving 95 per cent
confidence limits of the order of ±2 years when we are trying to estimate survival times of the
order of eight years. When applied to the Kenya data, described below, they gave a figure of
less than three years, which was unacceptably short. We have therefore been reluctantly
forced to the conclusion that an independent estimate of survival time is an essential piece of
information for our purposes, for which there is no readily available substitute.
John Blacker and Basia Zaba
Supplement 2 to Health Transition Review Volume 7, 1997
56
A second problem with the practical applications is that the models are of stable
populations with constant fertility, mortality and age structure, and in which the HIV/AIDS
epidemic has also stabilized, so that prevalence too is constant. In practice we are dealing with
situations where the epidemic is still growing and where both fertility and mortality from
causes other than AIDS may be changing. In some countries badly affected by the AIDS
epidemic, such as Zimbabwe and Kenya, fertility has been falling rapidly in recent years.
Current growth rates will therefore differ from the stable population growth rates in our
models, and even if recent growth rates can be estimated from successive censuses these will
not persist, and would not be suitable inputs into the estimating procedure. These differences
between the models and actual populations will affect our calculations in two ways: the
underlying age structures will differ, and the mean age at infection will change as the disease
spreads from age group to age group.
Changes in age structure will affect the prevalence, but not the lifetime risk, since the
latter, like the expectation of life and the total fertility rate, is an index which is independent
of the age structure. We have investigated the effect of a changing age structure on prevalence
using the model fitted to the Kenya data described below. The age-specific prevalences from
the female stable population model were combined with the projected female population of
Kenya for 1995 (CBS 1996 b: appendix III); the overall prevalence for the population aged 15
and over worked out at 7.8 per cent as against 7.5 per cent in the model, which implied that
we had overestimated lifetime risk by about one percentage point. Such an error can be
regarded as trivial compared with the other margins of uncertainty surrounding our estimates.
If the mean age at infection rises as the epidemic spreads, the mean age at death from
AIDS will also rise. But, because of the long period of incubation, the current mean age at
death will imply an age at infection appropriate for a time several years before (which may
partly explain why our regression estimates of survival time for Kenya were unacceptably
short). Furthermore the mean age at death will also be affected by changes in the age structure
of the population.
To assess the possible nature and magnitude of these changes, we have calculated, first,
the mean age of the age-specific AIDS prevalence rates of the model projections made by
Anderson (1989:  Annex Table 14), and, second, the mean age of the AIDS cases obtained by
multiplying their prevalence rates by their projected populations. Thus the first would
measure the epidemiological changes only:  the way the epidemic spreads from age group to
age group; the second will measure the combined effects of the epidemiological and age
structure changes.
The mean age of the AIDS prevalences rose by about two years over the 20-year period
of the projections. In contrast the mean age of the AIDS cases rose by only 0.3 years over the
same period. This implied that the epidemiological and age structure changes were having
compensating effects. Their net result would be to introduce a small downward bias in the
estimates of lifetime risk, thus compensating for the bias in the prevalences. We may conclude
therefore that our stable population models can be used to estimate lifetime risk in current
populations, provided they are not regarded as anything more than ‘ball-park’ estimates.
Linearization of the relationships and regression estimates
In order to make our model useful for estimating lifetime risk from commonly available data,
we investigated the relationship between lifetime risk and our chosen indicators in a variety of
circumstances. We generated 1000 model simulations with a wide range of values of HIV
prevalence, non-AIDS mortality, mean age at infection, mean age at death from AIDS, mean
age at first birth, survival time, vertical transmission ratio and fertility. The full model of HIV,
population growth and structure is controlled by 22 different parameters describing biological
and behavioural factors which govern fertility, mortality and HIV transmission. Even if each
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parameter were only allocated one of two values, high and low, to produce simulations
covering every possible combination of parameters would require 222 = 4,194,304 different
simulations. Since the amount of computer power needed to generate, store and analyse this
would be excessive, an alternative strategy was adopted, whereby in each of the 1000
simulations each parameter was assigned a random value between its upper and lower limits.
The scatter diagram of the relationship between lifetime risk and prevalence in the female
population derived from these models is shown in Figure 5. It will be seen that the trend is
curvilinear, a feature which is already apparent in Figures 1 to 4. The curvature can however
be eliminated if we plot the log-odds (i.e. the natural logarithms of the odds-ratios) of the
lifetime risks against the corresponding log-odds of the prevalences, as shown in Figure 6.
This linearization facilitates the use of multiple regression for analysing the effects of the
different variables in the determination of lifetime risk. The independent variables, apart from
prevalence, included mean age at first birth, total fertility, mean age at death from AIDS,
mean survival time and the vertical transmission rate. An additional term of the product of the
life expectancy of non-AIDS mortality and the log-odds of the prevalence was included, since
the lines of the log-odds transformation of Figure 1, although straight, were not quite parallel.
The log-odds of the risks generated by the models were then regressed against the log-
odds of the prevalences and the other variables. The regression analysis was carried out using
ordinary least squares regression in the STATA (1997) package. Three separate regressions
were made for each of the net risks considered as dependent variables: log odds of lifetime
risk, log odds of risk for adults conditional on surviving to age ten, and the log odds of the net
risk of dying from AIDS before age ten. The results are shown in Table 3. Apart from the
independent variables listed in this table, we also experimented with the mean age of
childbearing in the population, but in all cases this proved statistically insignificant, even at a
ten per cent level, and was dropped from the final regressions. Unsurprisingly, the vertical
transmission ratio proved to have an insignificant relationship with adult lifetime risk, and
childhood risks were not significantly affected by the adult survival time after HIV infection,
nor by the cross-product of life expectancy and prevalence. All the dependencies listed in
Table 2 were highly significant at probability levels less than 0.1 per cent.
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Figure 5
Table 3
Regression coefficients for the estimation of log-odds of net lifetime risk
Risk at birth Risk at age
10
Risk of dying from AIDS
before age 10
Constant -2.50 -1.43 -3.47
Log-odds prevalence 0.39 0.49 0.84
Life expectancy 0.06 0.05 0.01
Life exp.x log-odds prevalence 0.01 0.01
Vertical transmission ratio 0.35 3.62
Mean age at first birth 0.03 0.03 0.07
Total fertility 0.03 0.02 0.06
Mean age at death from AIDS 0.03 0.03 -0.03
Survival time -0.13 -0.15
Regression statistics
R-squared 0.99 0.99 0.99
Standard error 0.10 0.08 0.07
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Figure 6
In the case of adult risk, and overall lifetime risk, the factors with the most influence were
prevalence, its cross-product with life expectancy, life expectancy, survival time, and mean
age at death from AIDS. Dropping the two factors relating to the age pattern of fertility would
lower the amount of variance explained from around 99 per cent to 95 per cent, thereby
raising the standard errors of the log odds estimates from around 0.09 to 0.17:  this is
equivalent to an error of 1-2 percentage points in the estimate of lifetime risk when this is of
the order of 15 per cent.
Although survival time with HIV is one of the most important factors, both from
theoretical considerations (equation 4) and as identified by the regression analysis above, we
explored the effects of leaving it out of the regression procedure. The results showed that the
amount of variance captured fell to around 90 per cent, and the standard errors of the log odds
of the risks rose to 0.24, that is around four percentage points in estimating a risk of the order
of 15 per cent. This we deemed unacceptable, which is why the results of regressions without
survival time amongst the independent variables are not shown here. Figure 7 shows how well
predicted values of lifetime risk based on regressions with and without survival time compare
with the actual values generated in the model simulations.
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Figure 7
Comparison of regression predictions and model output
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A worked example: Kenya
As mentioned above, the National AIDS Control Programme of the Government of Kenya has
estimated that the national HIV prevalence in 1995 was 7.5 per cent of the population aged 15
and over (NACP 1996). They have assumed a similar level of prevalence among males and
females. They also estimate the vertical transmission ratio to be ‘30 to 40 per cent’; we have
therefore adopted a value of 35 per cent. Figures of registered AIDS cases for the years 1988
to 1996 by sex and age group have also kindly been supplied by the NACP; from these we
have estimated the mean age at death from AIDS for females to be 30.6 years.
The expectation of life for females in the absence of AIDS was taken as 61.4 years: this
was the value obtained from the model life tables fitted to the data on child survival and
orphanhood from the 1979 and 1989 censuses, and represented average values for the
intercensal period, when mortality from AIDS could be regarded as negligible (CBS 1996a).
Since mortality, both of children and adults, had been falling steadily before the 1989 census,
it might seem reasonable to assume that mortality from causes other than AIDS would
continue to fall into the 1990s. However this is a questionable assumption, and in the absence
of hard evidence we have used the 1979-89 estimates as being the latest available. If, in so
doing, we have overestimated non-AIDS mortality, we will have underestimated the lifetime
risks of contracting HIV
The cohort mean age of women at the birth of their first child was calculated from the
proportions of childless women in each age group (adjusted by the El Badry correction)
obtained from the 1989 census, which gave a figure of 20.9 years. Similar calculations using
the 1993 DHS data gave an identical result. Total fertility was taken to be 5.13, based on the
the analysis of the 1989 census and 1993 DHS (CBS 1996b:13).
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Our attempts to estimate mean survival time by regression gave unacceptable results. We
know of no longitudinal studies in Kenya, but in Uganda and Tanzania such studies have
suggested that seven years would be a plausible guess. The lack of information on survival
times in Kenya constitutes the biggest gap in our knowledge for the purpose of these
calculations.
When these parameters were multiplied by the regression coefficients shown in Table 3,
this produced an estimate of overall lifetime risk of dying from AIDS of 31.3 per cent for a
female born in Kenya subject to the current age-specific infection risks. Breaking down the
risks separately for child and adult deaths, we find that the risk of dying from vertically
transmitted AIDS is 3.6 per cent, and the risk of dying from AIDS for someone who survives
to age ten is 32.8 per cent. The reason for the higher probability of dying from AIDS for those
who survive to age ten than for the newborn is that infant and child mortality from other
causes is also high in Kenya; in the absence of AIDS, we would expect about 12.4 per cent of
female children to die before age ten in any case.
As an additional check on these regression results, we have constructed a single stable
population model such that prevalence of HIV, non-AIDS mortality, mean age at first birth
and at death from AIDS, total fertility rate, survival time and vertical transmission ratio were
as close to the Kenya female values as possible. Table 4 shows the female stabilized age
distribution, the age-specific prevalences, and the number of infected persons in each age
group out of a total of 10,000; and the gross and net risks at different ages. The net lifetime
risks at birth and at age ten from this best fitting model are about two percentage points lower
than the regression-based estimates. But they confirm the general level of the lifetime risk
estimate as around 30 per cent, some four times higher than the prevalence estimate.
Table 4
Age patterns of infection in the model for Kenya females
Age group Age
distribution
Prevalence (%) Infected
persons
Age Net risk
(%)
Gross risk
(%)
 0- 4 1565 1.50 23 0 29.20 39.40
 5- 9 1338 0.00 0 5 29.90 36.80
10-14 1205 0.10 1 10 30.10 36.80
15-19 1077 4.40 47 15 30.30 36.20
20-24 912 12.80 117 20 29.00 33.00
25-29 741 14.40 107 25 24.10 27.00
30-34 604 11.70 71 30 18.10 20.20
35-39 501 8.70 44 35 12.80 14.10
40-44 422 6.70 28 40 8.50 9.30
45-49 357 4.70 17 45 5.10 5.50
50-54 305 2.50 8 50 2.60 2.80
55-59 261 1.20 3 55 1.20 1.40
60-64 220 0.60 1 60 0.60 0.70
65-69 179 0.30 1 65 0.30 0.30
70-74 138 0.10 70 0.10 0.20
75+ 175 0.10 0 75 0.00 0.10
Total 10000 4.70 468
Total 15+ 5892 7.50 443
Table 4 explains this feature which was noted at the beginning of this paper: why the
lifetime risk is so much higher than the prevalence. The latter is calculated over the whole 15+
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age range, while the infections are concentrated in a relatively short age span. Thus
prevalence is low at the extremes of the distribution:  in the 15-19 age group which contains
many who have not yet been infected but may well be later, and at higher ages (45 and over)
where the survivors escaped infection while many of their contemporaries perished and have
therefore disappeared from the prevalence calculations.
We may conclude therefore that the estimated prevalence for 1995 of 7.5 per cent, or one
person in 13, implies that, of the children born in Kenya, almost one in three will die of AIDS,
leaving the other two to die of other causes. Although our calculations cannot do more than
indicate a rough order of magnitude, it is nevertheless a formidable figure which we feel
deserves wider recognition.
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